Zacks Investment Research
26 May 2026, 10:30 UTC · 2h ago
Source · https://www.zacks.com/stock/news/2926488/new-strong-sell-stocks-for-may-26th?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|new_zacks_5_rank_stocks-2926488
Read source
Search tags
Story key points
3 claims · impact-rated
Amerant Bancorp (AMTB) has seen its current year earnings consensus estimate revised downward by nearly 13.7% over the last 60 days and was added to the Zacks Rank #5 (Strong Sell) list. — Significant downward earnings revisions and a Strong Sell rating generally trigger selling pressure for a specific equity.
-0.60ADMA Biologics (ADMA) has seen its current year earnings consensus estimate revised downward by nearly 12.5% over the last 60 days and was added to the Zacks Rank #5 (Strong Sell) list. — Significant downward earnings revisions and a Strong Sell rating generally trigger selling pressure for a specific equity.
-0.60Adecco (AHEXY) has seen its current year earnings consensus estimate revised downward by 9% over the last 60 days and was added to the Zacks Rank #5 (Strong Sell) list. — Downward earnings revisions and a Strong Sell rating suggest negative sentiment and potential price decline.
-0.50Impact vectors
1 dimensions · 9 clusters
Market reaction
0 bid · 10 offered
No stock impact ranking available yet.
Ticker attribution
Model heads
The company was added to the Zacks Rank #5 Strong Sell list and its earnings estimates were revised 12.5% downward.
The company was added to the Zacks Rank #5 Strong Sell list and its earnings estimates were revised 13.7% downward.
The company was added to the Zacks Rank #5 Strong Sell list and its earnings estimates were revised 9% downward.
No ticker relationship head found.
